查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1352780

全球个人化医疗市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

Global Personalized Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球个人化医疗市场需求预计将从 2022 年的 6,380.2 亿美元增至 2030 年的近 1,2092.1 亿美元，2023-2030 年研究期间复合年增长率为 8.32%。

个人化医疗着重于透过收集有关个人遗传学的资讯来进行个人化治疗。它透过识别个体特有的某些基因并根据它们制定治疗方案，彻底改变了医学领域。它还有助于找出使人容易患某些疾病的基因，并尝试预防这些疾病。它透过提供有关恶性肿瘤的基本资讯来规划治疗过程或检查患者对治疗的反应程度，特别有助于治疗癌症。这是一种客製化的治疗方法，可以按时为患者提供正确的治疗。个人化医疗有助于改善患者的生活品质并显着降低治疗成本。

市场动态：

在研究期间，个人化医疗市场呈现出良好的成长动能。人们越来越关註生物标记或基因在疾病诊断、治疗和预测中的作用，以促进个人化医疗的发展，这促进了市场的成长。市场成长也归因于癌症和自体免疫等疾病的数量不断增加，与其他疗法相比，个人化医疗在治疗这些疾病方面非常有效。药物基因组学领域或研究人的 DNA 如何影响其对药物的反应方式的进展将为开发针对患者的药物创造有利的氛围。这将推动个人化药物市场的发展。降低用药错误和有害药物反应的风险、快速见效以及这些药物的客製化效果将促进该领域的研究和开发，并为个人化药物创造市场收入。政府对这些药物的弹性政策将为市场创造新的成长机会。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球个人化医疗市场的每个细分市场进行了包容性评估。个人化医疗产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲个人化医疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。个人化医疗市场的主要参与者包括 Illumina Inc.、GE Healthcare、Danaher Corporation (Cepheid Inc.)、Abbott、QIAGEN、Exact Sciences Corporation、ASURAGEN INC.、Biogen、Dako A/S、Exagen Inc.、Precision Biologics、 Celera Diagnostics LLC、Decode Genetics Inc.、Genelex、IBM、Genentech Inc.、23andME Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：个人化医疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球个人化医疗市场分析：依产品分类

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 个人化医学诊断（基因检测、DTC 诊断、深奥实验室服务、深奥实验室检验）
  • 个人化医疗治疗（製药、基因组医学、医疗器材）
  • 个人化医疗（远距医疗、健康资讯科技）
  • 个人化营养与健康（零售营养、补充与替代医学）

第 7 章：全球个人化医疗市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：个人化医疗公司的竞争格局

  • 个性化医疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Illumina Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE Healthcare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danaher Corporation (Cepheid Inc.)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • QIAGEN
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Exact Sciences Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ASURAGEN INC.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biogen
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dako A/S
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Exagen Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Precision Biologics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Celera Diagnostics LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Decode Genetics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Genelex
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IBM
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Genentech Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • 23andME Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11219103

The global demand for Personalized Medicine Market is presumed to reach the market size of nearly USD 1209.21 BN by 2030 from USD 638.02 BN in 2022 with a CAGR of 8.32% under the study period 2023 - 2030.

Personalized Medicine focuses on individualized treatment by gathering information about a person's genetics. It has revolutionized the field of Medicine by identifying certain genes specific to an individual and planning treatment based on them. It also helps to find out genes that make a person vulnerable to certain diseases and attempts to prevent them. It especially helps in treating cancer by giving essential information about a malignant tumour to plan the course of treatment or check how well the patient responds to the treatment. This is a customized treatment method to offer the correct treatment to the patient on time. Personalized Medicine helps improve patient's quality of life and significantly reduces treatment costs.

MARKET DYNAMICS:

The personalized medicine market shows favourable growth during the study period. The growing focus on the role of the biomarker or gene in the diagnosis, treatment, and prediction of diseases for the development of personalized Medicine has contributed to the market's growth. The market growth is also attributed to the fact that the number of diseases like cancer and autoimmune is increasing, and personalized Medicine is highly effective in treating them compared to other therapies. The progress in the field of pharmacogenomics or the study of how a person's DNA affects his way of responding to medications will create a favorable atmosphere for developing patient-specific drugs. This will boost the market for personalized medicines. Reduced risk for medication errors and harmful drug reactions, fast results, and customized effects of these medicines will facilitate the research and development in this field and generate market revenue for personalized medicines. Flexible government policies toward these medicines will create new growth opportunities in the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized medicine. The growth and trends of personalized medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the personalized medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Personalized Medicine Diagnostics (Genetic Testing, Dtc Diagnostics, Esoteric Lab Services, Esoteric Lab Tests)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices)
  • Personalized Medical Care (Telemedicine, Health Information Technology)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Personalized Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the personalized medicine market include Illumina Inc., GE Healthcare, Danaher Corporation (Cepheid Inc.), Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN INC., Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC, Decode Genetics Inc., Genelex, IBM, Genentech Inc., 23andME Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PERSONALIZED MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Historic and Forecast Sales by Regions
  • 6.5 Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Historic and Forecast Sales by Regions
  • 6.6 Personalized Medical Care (Telemedicine, Health Information Technology) Historic and Forecast Sales by Regions
  • 6.7 Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Historic and Forecast Sales by Regions

7 . GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PERSONALIZED MEDICINE COMPANIES

  • 8.1. Personalized Medicine Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PERSONALIZED MEDICINE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Illumina Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. GE Healthcare
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Danaher Corporation (Cepheid Inc.)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Abbott
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. QIAGEN
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Exact Sciences Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. ASURAGEN INC.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Biogen
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Dako A/S
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Exagen Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Precision Biologics
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Celera Diagnostics LLC
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Decode Genetics Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Genelex
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. IBM
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Genentech Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. 23andME Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Market Sales by Geography (USD MN)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Market Sales by Geography (USD MN)
  • Personalized Medical Care (Telemedicine, Health Information Technology) Market Sales by Geography (USD MN)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Market Sales by Geography (USD MN)
  • Global Personalized Medicine Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Personalized Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Personalized Medicine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Market Sales by Geography (USD MN)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Market Sales by Geography (USD MN)
  • Personalized Medical Care (Telemedicine, Health Information Technology) Market Sales by Geography (USD MN)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.